Evaluation of DASATINIB Monotherapy Efficacy in Acute Myeloid Leukemia Patients Refractory to VENETOCLAX-AZACITIDINE
Clinical trial NCT06055621 · RECRUITING
Trial details
- NCT number
- NCT06055621
- Sponsor
- Institut Paoli-Calmettes
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-22
- Primary completion
- 2026-07-08
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.